Find 3 more new buyers similar to 
Altis Biosystems
2023-present (2 years)
Altis Biosystems specializes in capturing the complexity of the human gut to enable pharmaceutical companies to identify effective compounds earlier, reduce animal testing, and facilitate a faster, cheaper, and safer drug development process. They offer RepliGut Systems, a collection of in vitro models designed for pre-clinical drug discovery, replicating the complex structure of the human small intestine and colonic epithelium. These systems, derived from adult human donor stem cells, provide valuable data insights and reduce the need for animal testing, ultimately enhancing clinical trial performance. Altis Biosystems aims to improve compound screening, disease modeling, and microbiome research through their innovative technologies.
